I
Inception Sciences
Creating new biotechnology companies
About Inception Sciences
Inception Sciences is a biotechnology company focused on creating new companies that develop novel treatments for unmet medical needs. The company operates in multiple therapeutic areas, including neuro-regenerative therapies, eye diseases, anti-tumor immunity pathways, and kidney diseases. Inception's business model involves leveraging cutting-edge scientific breakthroughs and multidisciplinary wetlab capabilities to build transformational biotechnology companies. They partner with Versant Ventures to identify and develop innovative therapeutics. Inception serves clients in the pharmaceutical and biotechnology sectors, aiming to advance small molecule therapeutics through preclinical and clinical development stages. The company generates revenue through the development and acquisition of its portfolio companies, as evidenced by past acquisitions by Ophthotech and Roche.
Source: Dealroom company dataAt a glance
- Founded
- 2011
- Headquarters
- San Diego, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Inception Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Inception Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.